07/02/2024

EuropaBio joins the PRIMED PROJECT CONSORTIUM

EuropaBio, the leading voice for the biotechnology industry in Europe, has joined the PRIMED (Redesigning the Primary Sector for Maximizing Bioeconomy Development) PROJECT CONSURTIUM, launched on January 12th, 2024, and supported by the European Union’s Horizon Europe Program.
01/12/2023

Agri-Food Chain Coalition launches EU Strategic Agenda 2024-2029

The Agri-Food Chain Coalition (AFCC) has published a recommendation for the EU Strategic Agenda 2024-2029 to include the strengthening of the European food autonomy and resilience as well as enhancing the competitiveness and sustainability of the entire EU-Agri food chain.
27/10/2023

EFIB Rotterdam Statement 2023

As the EU looks ahead to the European elections in 2024, with a new EU Commission mandate and Work Programme, EuropaBio reviews European strategies and ambitions where biotechnology plays a key role. Ursula von der Leyen’s State of the European Union address of 13 September announced an ‘EU Biotech and Biomanufacturing Initiative’ under the heading of ‘An Economy that Works for People’1. Europe needs to be ambitious for this, particularly when considering the ongoing changes in global perspective on biotechnology which were highlighted in the 2022 Vilnius Statement.
16/10/2023

A global Europe – the role of transformative legislation for biotech. EuropaBio Nacional Associations Spanish Council Presidency Summit

The Spanish Presidency of the Council of the European Union has established several priorities for the second half of 2023 to ensure Europe's global position and strategic autonomy, including promoting the transition towards a more sustainable agri-food production model and strengthening EU's health autonomy through European-based innovation.
04/09/2023

Factsheet – The Biotech Journey: From Bench to Patients

Innovations in healthcare biotechnology come from a vast array of stakeholders working with each other over extensive periods of time. In this factsheet we embark on a journey through the intricate ecosystem of healthcare biotechnology and highlight the time, expertise, and resources it takes to get innovative biotechnologies from bench to patient.